[1]
|
姜洪池, 代文杰, 胡震. 门静脉高压症外科治疗的保脾问题[J]. 外科理论与实践, 2006, 11(3): 193-195.
|
[2]
|
祁小龙. 肝硬化门静脉高压症前期: 一个肝硬化病程进展的特定阶段[J]. 中华医学杂志, 2022, 102(8): 535-537.
|
[3]
|
朱继业, 王刚. 门静脉高压症外科治疗现状与展望[J]. 中国普外基础与临床杂志, 2015, 22(11): 1289-1292.
|
[4]
|
中华外科学分会门静脉高压症学组. 肝硬化门静脉高压症食管胃底静脉曲张破裂出血的诊治共识(2015版) [J]. 中华普通外科杂志, 2016, 31(2): 167-170.
|
[5]
|
盛基尧, 刘水, 杨永生, 等. 肝硬化门静脉高压症食管胃静脉曲张出血诊疗进展[J]. 中华外科杂志, 2020, 58(10): 808-812.
|
[6]
|
杨镇. 选择性贲门周围血管离断术的解剖学命名和操作步骤[J]. 外科理论与实践, 2009, 14(1): 82-84.
|
[7]
|
Zhao, Y. and Wang, C. (2018) The Therapeutic Effect of Splenectomy Pluss Elective Pericardial Devascularization Versus Conventional Pericardial Devas-cularization on Portal Hypertension in China: A Meta Analysis. Oncotarget, 9, 15398-15408. https://doi.org/10.18632/oncotarget.23857
|
[8]
|
曾珂芮. 肝硬化门静脉高压症外科治疗中脾保留术研究进展[J]. 现代医药卫生, 2019, 35(14): 2169-2172.
|
[9]
|
汪谦. 门静脉高压症脾脏保留与切除之争[J]. 外科理论与实践, 2007, 12(2): 114-115.
|
[10]
|
Orozco, H., Mercado, M.A., MarIinez, R., et al. (1998) Is Splenectomy Necessary in Devascularization Procedures for Treatment of Bleeding Portal Hypertension? The Archives of Surgery, 133, 36-38.
https://doi.org/10.1001/archsurg.133.1.36
|
[11]
|
霍景山, 陈积圣. 肝硬化门静脉高压症脾保留术的研究进展[J]. 中华肝胆外科杂志, 2006, 12(6): 428-429.
|
[12]
|
李恩山, 赵连德, 朱立东, 等. 脾次全切除腹膜后移位加断流术对门静脉高压性胃病的影响[J]. 中国普通外科杂志, 2004, 13(8): 564-567.
|
[13]
|
夏穗生, 曹秀峰, 姜洪池. 现代脾脏外科学[M]. 南京: 江苏科学技术出版社, 2000.
|
[14]
|
Spirer, Z., Zakuth, V., Diamant, S., et al. (1977) Decreased Tuftsin Concentrations in Patients Who Have Undergone Splenectomy. British Medical Journal, 2, 1574-1576. https://doi.org/10.1136/bmj.2.6102.1574
|
[15]
|
黄凤瑞, 褚海波, 李银良, 等. 门静脉高压症巨脾大部切除后残脾及其免疫功能研究(附30例报告) [J]. 中国实用外科杂志, 1997(3): 36-37.
|
[16]
|
谢鹏举. 保留脾脏的选择性断流联合脾肾静脉桥式分流术对门静脉高压症患者免疫功能的影响[J]. 湖北民族学院学报(医学版), 2013, 30(1): 39-41.
|
[17]
|
Sutton, J.M., Nussbaum, M.S., Vu, D., et al. (2015) Splenopneumopexy: Decompression of Portal Hyper-tension in the Setting of Portal Venous Occlusive Disease. Digestive Diseases & Sciences, 60, 1101-1105.
https://doi.org/10.1007/s10620-014-3405-y
|
[18]
|
李小珍, 罗地来, 朱程, 等. 保留脾脏的选择性断流联合脾肾静脉桥式分流术对肝硬化合并门静脉高压患者免疫功能的影响[J]. 重庆医学, 2013, 42(1): 24-26.
|
[19]
|
陶崇林, 张启瑜. 门静脉高压症时脾脏免疫功能[J]. 肝胆胰外科杂志, 2007, 19(1): 55-56, 59.
|
[20]
|
王永向, 高亮一, 李国威, 李宗芳. 脾脏巨噬细胞对门脉高压症脾亢及脾脏免疫功能的影响[J]. 西安医科大学学报, 2000, 21(6): 557-559.
|
[21]
|
陈积圣, 耿海涛. 门脉高压脾亢的保脾手术[J]. 肝胆外科杂志, 1996(4): 196-197.
|
[22]
|
Yao, Y.-M., Liu, Q.-G., Wei, Y., et al. (2003) Effect of Spleen on Immune Function of Rats with Liver Cancer Complicated by Liver Cirrhosis. Hepatobiliary & Pancreatic Diseases International, 2, 242-246.
|
[23]
|
曾仲, 马宏敏. 脾次全切除术对肝纤维化影响的实验研究[J]. 中华肝胆外科杂志, 2001, 7(6): 359-362.
|
[24]
|
冷希圣. 肝移植时代门静脉高压症治疗策略[J]. 中国实用外科杂志, 2009, 29(5): 373-376.
|
[25]
|
朱卫华, 刘以俊, 张哲栋,等. 保脾断流术与切脾断流术治疗胃底食管曲张静脉破裂出血的疗效及安全性分析[J]. 中华普通外科杂志, 2018, 33(7): 540-543.
|
[26]
|
Orozco, H., et al. (1960) Is Splenectomy Necessary in Devascularization Procedures for Treatment of Bleeding Portal Hyperten-sion? Archives of Surgery, 133, 36-38. https://doi.org/10.1001/archsurg.133.1.36
|
[27]
|
Ni, Y.-B., Gao, P.-J., Wang, D., Li, Z. and Zhu, J.-Y. (2015) Esophagogastric Devascularization without Splenectomy in Portal Hypertension: Safe and Effective? Hepatobiliary & Pancreatic Diseases International, 14, 276-280.
https://doi.org/10.1016/S1499-3872(15)60328-9
|
[28]
|
Akahoshi, T., Hashizume, M., Tanoue, K., et al. (2002) Role of the Spleen in Liver Fibrosis in Rats May Be Mediated by Transforming Growth Factor β-1. Journal of Gastroenter-ology and Hepatology, 17, 59-65.
https://doi.org/10.1046/j.1440-1746.2002.02667.x
|
[29]
|
Murata, K., Shiraki, K., Sugimoto, K., et al. (2001) Sple-nectomy Enhances Liver Regeneration through Tumor Necrosis Factor (TNF)-Alpha Following Dimethylnitrosa-mine-Induced Cirrhotic Rat Model. Hepato-Gastroenterology, 48, 1022-1027.
|
[30]
|
汪谦, 夏穗生, 崔怀波, 等. 脾脏及促吞噬肽对肝硬化过程不同细胞因子基因表达的调控作用[J]. 1996, 13(3): 147-148.
|
[31]
|
张晓剑. 脾切断流术对肝硬化门静脉高压患者血清HGF、TGF-β1及肝功能的影响[J]. 河南医学研究, 2015, 24(12): 72-73.
|
[32]
|
吴晓峰, 伏志, 刘召波, 等. 肝硬化门静脉高压患者行脾切断流术后早期门静脉血栓形成的原因分析[J]. 临床肝胆病杂志, 2015, 31(3): 400-403.
|
[33]
|
杨栋. 脾切断流术对肝硬化门静脉高压患者肝功能及血清HGF、TGF-β的影响[J]. 中外医疗, 2017, 36(10): 49-51, 55.
|
[34]
|
陆新良, 朱志鑫, 蔡建庭, 等. 脾切除有助于纠正肝硬化患者氧化和抗氧化的失衡[J]. 临床肝胆病杂志, 2002, 18(5): 313-315.
|
[35]
|
Trautwein, C., Friedman, S.L., Schuppan, D. and Pinzani, M. (2015) Hepatic Fibrosis: Concept to Treatment. Journal of Hepatology, 62, S15-S24. https://doi.org/10.1016/j.jhep.2015.02.039
|
[36]
|
齐硕. 肠道菌群与肝纤维化的相关性[J]. 济宁医学院学报, 2021, 44(1): 5-9.
|
[37]
|
Asanoma, M., Ikemoto, T., Mori, H., et al. (2014) Cytokine Expression in Spleen Affects Pro-gression of Liver Cirrhosis through Liver-Spleen Cross-Talk. Hepatology Research, 44, 1217-1223. https://doi.org/10.1111/hepr.12267
|
[38]
|
Aoyama, T., Kuwahara-Arai, K., Uchiyama, A., et al. (2017) Spleen-Derived Lipocalin-2 in the Portal Vein Regulates Kupffer Cells Activation and Attenuates the Development of Liver Fibrosis in Mice. Laboratory Investigation, 97, 890-902. https://doi.org/10.1038/labinvest.2017.44
|
[39]
|
曹志新, 陈孝平, 吴在德. 肝细胞癌合并肝硬化患者肝脾联合切除术后免疫功能变化的研究[J]. 中华外科杂志, 2002, 40(2): 97-99.
|
[40]
|
杨宏志, 张涌泉, 许景洪, 等. 脾切除对乙肝肝硬化性门静脉高压合并脾功能亢进患者免疫功能、肝功能以及血常规的影响[J]. 广西医学, 2015, 37(11): 1591-1594.
|
[41]
|
邓骏. 全腹腔镜脾切除术联合贲门周围血管离断对脾功能亢进患者免疫功能的影响研究[J]. 中华普外科手术学杂志: 电子版, 2019, 13(4): 362-365.
|
[42]
|
吴厚慧, 徐鹿平, 刘凤强, 等. 肝硬化巨脾切除对免疫功能的影响[J]. 肝胆胰外科杂志, 2000, 12(2): 80-82.
|
[43]
|
张怡杰. 脾脏切除对门脉高压症病人NK细胞活性的影响[J]. 外科, 1996(4): 136-138.
|
[44]
|
Tsochatzis, E.A., Bosch, J. and Burroughs, A.K. (2014) Liver Cirrhosis. Lancet, 383, 1749-1761.
https://doi.org/10.1016/S0140-6736(14)60121-5
|
[45]
|
黄智铭. 门静脉高压症的内科治疗[J]. 肝胆胰外科杂志, 2019, 31(8): 467-472.
|
[46]
|
吴志勇. 门静脉高压症血流动力学研究现况[J]. 肝胆外科杂志, 2004, 12(5): 321-323.
|
[47]
|
花荣, 吴志勇, 孙勇伟, 邱江锋, 罗蒙, 徐庆, 徐琳. 断流术中门静脉压力变化及术后再出血的临床研究[J]. 中华普通外科杂志, 2007, 22(3): 194-196.
|
[48]
|
陈韵壕, 马靖, 刘清波, 王卫东. 腹腔镜脾切除联合选择性贲门周围血管断流术对门静脉高压症患者肝脏体积及肝储备功能的影响[J]. 中国微创外科杂志, 2021, 21(11): 982-986.
|
[49]
|
Quintini, C., Hirose, K., Hashimoto, K., et al. (2008) “Splenic Artery Steal Syndrome” Is a Mis-nomer: The Cause Is Portal Hyperperfusion, Not Arterial Siphon. Liver Transplantation, 14, 374-379. https://doi.org/10.1002/lt.21386
|
[50]
|
Oh, J.W., Ahn, S.M., Kim, K.S., et al. (2003) The Role of Splenectomy in Patients with Hepatocellular Carcinoma and Secondary Hypersplenism. Yonsei Medical Journal, 44, 1053-1058. https://doi.org/10.3349/ymj.2003.44.6.1053
|
[51]
|
张磊, 温新元, 杨东昌, 等. 脾切除断流术治疗肝硬化门静脉高压的效果以及对患者生存质量和肝功能指标的影响[J]. 肝脏, 2018, 23(8): 711-714.
|
[52]
|
李广俊, 蔡日. 脾切除联合门奇静脉断流术治疗肝硬化门静脉高压合并脾亢对患者营养状态的影响[J]. 罕少疾病杂志, 2021, 28(4): 49-50.
|